{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:38:39Z","timestamp":1789349919318,"version":"build-2803163510"},"reference-count":34,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,12,2]],"date-time":"2008-12-02T00:00:00Z","timestamp":1228176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2009,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The objective was to analyze the metric properties of the Jankovic Rating Scale (JRS) and a self\u2010rating patient response outcome scale, the Blepharospasm Disability Index (BSDI\u00a9), in blepharospasm patients. Data from a randomized, double\u2010blind, active\u2010control clinical trial in 300 patients with blepharospasm treated with either botulinum toxin type A (Botox\u00ae) or NT201 (Xeomin\u00ae) were used to evaluate the metric properties of the JRS and the BSDI compared with the Patient Evaluation of Global Response (PEGR) and Global Assessment Scale (GAS). The internal consistency of the BSDI was high, Cronbach's Alpha = 0.88, and the retest reliability of the BSDI single items was adequate, Spearman's rank coefficient = 0.453 &lt; r &lt; 0.595. The correlation between JRS sum score and BSDI weighted mean score was r = 0.487 (baseline) and r = 0.737 (control visit), respectively. Using the GAS and PEGR, the results suggest that a change of 2 points in the JRS and of 0.7 points in the BSDI are clinically meaningful. JRS and BSDI are objective indicators of clinical efficacy as suggested by their good validity when compared with physicians' and patients' rating scales. Both, JRS and BSDI, can be used to reliably assess blepharospasm in treatment trials. \u00a9 2008 Movement Disorder Society<\/jats:p>","DOI":"10.1002\/mds.22368","type":"journal-article","created":{"date-parts":[[2008,12,2]],"date-time":"2008-12-02T16:45:22Z","timestamp":1228236322000},"page":"407-413","source":"Crossref","is-referenced-by-count":146,"title":["Relationship between various clinical outcome assessments in patients with blepharospasm"],"prefix":"10.1002","volume":"24","author":[{"given":"Joseph","family":"Jankovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Grafe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Goertelmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Comes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,2,23]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.iio.0000167238.26526.a8"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21084"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.51.6.767"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000311389.26145.95"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870030302"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002341-199809000-00002"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03330230060037"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000027361.73814.0E"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.068007"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70574-9"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-005-0323-3"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2007.11.003"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700444"},{"key":"e_1_2_5_15_2","first-page":"424","article-title":"Botulinum toxin type A purified neurotoxin complex for the treatment of blepharospasm: a dose\u2010response study measuring eyelid force","volume":"39","author":"Iwashige H","year":"1995","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.4.616"},{"key":"e_1_2_5_17_2","first-page":"206","article-title":"Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation","volume":"47","author":"Thussu A","year":"1999","journal-title":"Neurol India"},{"issue":"1","key":"e_1_2_5_18_2","first-page":"271","article-title":"Double\u2010blind controlled study of botulinum toxin for blepharospasm","volume":"35","author":"Fahn S","year":"1985","journal-title":"Neurology"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870100407"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.IOP.0000162429.97307.4D"},{"key":"e_1_2_5_21_2","first-page":"S77","article-title":"The Blepharospasm Disability Index (BSDI) for the assessment of functional health in focal dystonia","volume":"113","author":"Goertelmeyer R","year":"2002","journal-title":"Clin Neurophysiol"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(00)00146-9"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770060086012"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000026474.12594.0D"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.71.2.193"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200303000-00010"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/01676830490506041"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2004.00357.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603283341306"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.57.8.1224"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2001.00109.x"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000145508.84389.87"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.013441"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.1.116"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.60.6.693-a"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.22368","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.22368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T13:18:28Z","timestamp":1760966308000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.22368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,15]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,2,15]]}},"alternative-id":["10.1002\/mds.22368"],"URL":"https:\/\/doi.org\/10.1002\/mds.22368","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,15]]}}}